GlassScriptPhysician profile
Peter C Maki
NPI 1306886775
$4,343.79
in general payments reported to CMS, 2019-2025
26 companies · $908 in 2025
The $908 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $82.82 · 2021: $184 · 2022: $559 · 2023: $823 · 2024: $931 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,660.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $545.30 | 2019-2025 | Watchman Flx |
| Heartflow, INC. | $447.59 | 2019-2023 | Ffrct |
| Medtronic, INC. | $404.06 | 2021-2023 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Abbott Laboratories | $403.83 | 2022-2023 | Mitraclip |
| Atricure, INC. | $365.41 | 2024 | |
| Edwards Lifesciences Corporation | $255.88 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Angiodynamics, INC. | $232.52 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.21 | 2019-2025 | Lifevest |
| Cvrx, INC. | $193.47 | 2023-2025 | Barostim Neo System |
| Amgen INC. | $157.44 | 2019-2024 | Repatha |
| Inspire Medical Systems, INC. | $149.99 | 2025 | Inspire |
| Kestra Medical Technology Services, INC. | $144.02 | 2024 | Assure Wcd |
| Shockwave Medical, INC | $141.87 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $140.89 | 2019-2024 | (Bq9) Coronary Ivus |
| Medtronic Vascular, INC. | $102.69 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $94.95 | 2023 | Impella |
| Asahi Intecc USA, INC. | $89.16 | 2019 | |
| Bardy Diagnostics, INC. | $40.00 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $37.49 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.22 | 2019 | |
| Astellas Pharma US INC | $31.89 | 2019 | |
| Gilead Sciences, INC. | $25.13 | 2019 | |
| Siemens Medical Solutions USA, INC. | $23.29 | 2020 | |
| Blue Earth Diagnostics | $22.42 | 2022 | |
| Zoll Respicardia, INC. | $22.31 | 2025 | Remede System |
| Novartis Pharmaceuticals Corporation | $19.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Maki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.